Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Low rate of pneumococci non-susceptible to penicillin in healthy Swedish toddlers.

Skovbjerg S, Söderström A, Hynsjö L, Normark BH, Ekdahl K, Åhrén C.

Scand J Infect Dis. 2013 Apr;45(4):279-84. doi: 10.3109/00365548.2012.734919. Epub 2012 Oct 31.

PMID:
23113751
2.

Control of intestinal Nod2-mediated peptidoglycan recognition by epithelium-associated lymphocytes.

Duerr CU, Salzman NH, Dupont A, Szabo A, Normark BH, Normark S, Locksley RM, Mellroth P, Hornef MW.

Mucosal Immunol. 2011 May;4(3):325-34. doi: 10.1038/mi.2010.71. Epub 2010 Oct 27.

PMID:
20980996
3.

Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden.

Spindler C, Hedlund J, Jasir A, Normark BH, Ortqvist A.

Vaccine. 2008 Oct 9;26(43):5541-6. doi: 10.1016/j.vaccine.2008.06.073. Epub 2008 Jul 9.

PMID:
18602961
4.

An individual-based network model to evaluate interventions for controlling pneumococcal transmission.

Karlsson D, Jansson A, Normark BH, Nilsson P.

BMC Infect Dis. 2008 Jun 17;8:83. doi: 10.1186/1471-2334-8-83.

5.

The influence of in vitro fitness defects on pneumococcal ability to colonize and to cause invasive disease.

Fernebro J, Blomberg C, Morfeldt E, Wolf-Watz H, Normark S, Normark BH.

BMC Microbiol. 2008 Apr 18;8:65. doi: 10.1186/1471-2180-8-65.

6.

Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden.

Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalén C, Norgren M, Romanus V, Norrby-Teglund A, Normark BH.

Clin Infect Dis. 2007 Aug 15;45(4):450-8. Epub 2007 Jul 10.

PMID:
17638193
7.

Modeling the regulation of the competence-evoking quorum sensing network in Streptococcus pneumoniae.

Karlsson D, Karlsson S, Gustafsson E, Normark BH, Nilsson P.

Biosystems. 2007 Jul-Aug;90(1):211-23. Epub 2006 Aug 22.

PMID:
17011700
8.

Penicillin-resistant pneumococci in Sweden 1997-2003: increased multiresistance despite stable prevalence and decreased antibiotic use.

Högberg L, Ekdahl K, Sjöström K, Olsson-Liljequist B, Walder M, Melander E, Ringberg H, Normark BH.

Microb Drug Resist. 2006 Spring;12(1):16-22.

PMID:
16584303
9.

Endocarditis and pericarditis complicating pneumococcal bacteraemia, with special reference to the adhesive abilities of pneumococci: results from a prospective study.

Kan B, Ries J, Normark BH, Chang FY, Feldman C, Ko WC, Rello J, Snydman DR, Yu VL, Ortqvist A.

Clin Microbiol Infect. 2006 Apr;12(4):338-44.

10.

Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice.

Albiger B, Sandgren A, Katsuragi H, Meyer-Hoffert U, Beiter K, Wartha F, Hornef M, Normark S, Normark BH.

Cell Microbiol. 2005 Nov;7(11):1603-15.

PMID:
16207247
11.

Microbiology. A pathogen attacks while keeping up defense.

Normark S, Nilsson C, Normark BH.

Science. 2005 Feb 25;307(5713):1211-2. No abstract available.

PMID:
15731433
12.

Staphylococcal protein A inflames the lungs.

Normark BH, Normark S, Norrby-Teglund A.

Nat Med. 2004 Aug;10(8):780-1. No abstract available.

PMID:
15286774
13.

Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.

Darenberg J, Söderquist B, Normark BH, Norrby-Teglund A.

Clin Infect Dis. 2004 Mar 15;38(6):836-42. Epub 2004 Mar 1.

PMID:
14999628
14.

Capsular expression in Streptococcus pneumoniae negatively affects spontaneous and antibiotic-induced lysis and contributes to antibiotic tolerance.

Fernebro J, Andersson I, Sublett J, Morfeldt E, Novak R, Tuomanen E, Normark S, Normark BH.

J Infect Dis. 2004 Jan 15;189(2):328-38. Epub 2003 Dec 30.

PMID:
14722899
15.

Persistent infection with Helicobacter pylori and the development of gastric cancer.

Normark S, Nilsson C, Normark BH, Hornef MW.

Adv Cancer Res. 2003;90:63-89. Review.

PMID:
14710947
16.

Viridans streptococcal septicaemia in neutropenic patients: role of proinflammatory cytokines.

Ihendyane N, Sparrelid E, Wretlind B, Remberger M, Andersson J, Ljungman P, Ringdén O, Normark BH, Allen U, Low DE, Norrby-Teglund A.

Bone Marrow Transplant. 2004 Jan;33(1):79-85.

PMID:
14704660
17.

Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates.

Schmitz FJ, Beyer A, Charpentier E, Normark BH, Schade M, Fluit AC, Hafner D, Novak R.

J Infect Dis. 2003 Nov 15;188(10):1578-86. Epub 2003 Nov 5.

PMID:
14624385
18.

Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells.

Hornef MW, Normark BH, Vandewalle A, Normark S.

J Exp Med. 2003 Oct 20;198(8):1225-35.

19.

Group A streptococcal infections in Sweden: a comparative study of invasive and noninvasive infections and analysis of dominant T28 emm28 isolates.

Eriksson BK, Norgren M, McGregor K, Spratt BG, Normark BH.

Clin Infect Dis. 2003 Nov 1;37(9):1189-93. Epub 2003 Oct 1.

PMID:
14557963
20.

Evolution and spread of antibiotic resistance.

Normark BH, Normark S.

J Intern Med. 2002 Aug;252(2):91-106. Review.

21.

Changes in serotype distribution may hamper efficacy of pneumococcal conjugate vaccines in children.

Normark BH, Ortqvist A, Kalin M, Olsson-Liljequist B, Hedlund J, Svenson SB, Källenius G.

Scand J Infect Dis. 2001;33(11):848-50.

PMID:
11760167
22.

How neutrophils recognize bacteria and move toward infection.

Normark S, Normark BH, Hornef M.

Nat Med. 2001 Nov;7(11):1182-4. No abstract available.

PMID:
11689878

Supplemental Content

Loading ...
Support Center